Caulfield Timothy, Zarzeczny Amy, McCormick Jennifer, Bubela Tania, Critchley Christine, Einsiedel Edna, Galipeau Jacques, Harmon Shawn, Huynh Michael, Hyun Insoo, Illes Judy, Isasi Rosario, Joly Yann, Laurie Graeme, Lomax Geoff, Longstaff Holly, McDonald Michael, Murdoch Charles, Ogbogu Ubaka, Owen-Smith Jason, Pattinson Shaun, Premji Shainur, von Tigerstrom Barbara, Winickoff David E
Health Law Institute, Faculty of Law, University of Alberta, Edmonton, Canada.
Stem Cell Rev Rep. 2009 Jun;5(2):82-8. doi: 10.1007/s12015-009-9071-3. Epub 2009 May 27.
Few areas of recent research have received as much focus or generated as much excitement and debate as stem cell research. Hope for the therapeutic promise of this field has been matched by social concern associated largely with the sources of stem cells and their uses. This interplay between promise and controversy has contributed to the enormous variation that exists among the environments in which stem cell research is conducted throughout the world. This variation is layered upon intra-jurisdictional policies that are also often complex and in flux, resulting in what we term a 'patchwork of patchworks'. This patchwork of patchworks and its implications will become increasingly important as we enter this new era of stem cell research. The current progression towards translational and clinical research among international collaborators serves as a catalyst for identifying potential policy conflict and makes it imperative to address jurisdictional variability in stem cell research environments. The existing patchworks seen in contemporary stem cell research environments provide a valuable opportunity to consider how variations in regulations and policies across and within jurisdictions influence research efficiencies and directions. In one sense, the stem cell research context can be viewed as a living experiment occurring across the globe. The lessons to be gleaned from examining this field have great potential for broad-ranging general science policy application.
近年来,很少有研究领域像干细胞研究那样受到如此多的关注,引发如此多的兴奋和争论。该领域的治疗前景所带来的希望,与主要围绕干细胞来源及其用途的社会担忧不相上下。这种希望与争议之间的相互作用,导致了世界各地开展干细胞研究的环境存在巨大差异。这种差异叠加在司法管辖区内同样往往复杂且不断变化的政策之上,形成了我们所说的“拼凑的拼凑物”。随着我们进入干细胞研究的新时代,这种拼凑的拼凑物及其影响将变得越来越重要。国际合作中目前向转化研究和临床研究的进展,成为识别潜在政策冲突的催化剂,并使得解决干细胞研究环境中的司法管辖区差异变得势在必行。当代干细胞研究环境中现有的拼凑情况,为思考不同司法管辖区之间以及司法管辖区内部的法规和政策差异如何影响研究效率和方向提供了宝贵机会。从某种意义上说,干细胞研究背景可以被视为一场在全球范围内进行的实地试验。从研究这一领域中汲取的经验教训,对于广泛的一般科学政策应用具有巨大潜力。